The human IgM monoclonal antibody, PAT-SM6, derived from human tumour tissue [1], is a potential anti-cancer agent capable of inducing tumour cell apoptosis in pre-clinical models of human cancer [2]. This evidence concerns the gene CD40LG and cancer.